Read all news items about the AGE Reader and Diagnoptics.
Groningen, the Netherlands – March 11, 2014.
A recently published clinical paper by de Vos et al. (2014) demonstrates that the AGE Reader measurement is a strong predictor of mortality and coronary events in patients with peripheral artery disease. The added value of the AGE Reader in predicting the cardiovascular risk of diabetes and renal failure was already well known . The present publication extends its (independent and additive) predictive power to the much wider group of persons with atherosclerosis.
The abstract of this publication can be found here
Would you like to learn more about our products? Request any information you wish to receive here.
If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.
More information about Diagnoptics.
Information on Diagnoptics' products and Advanced Glycation Endproducts.
Information about Advanced Glycation Endproducts, the AGE measurement and clinical validation.